President Donald Trump is keeping biotech analysts busy trying to match up his opaque drug-pricing rhetoric with the complexities of the U.S. health-care system. Mr. Trump said on Twitter Tuesday morning that he is, “working on a new system where there will be competition in the Drug Industry.” He also cited an effort to “get rid […]

Source: Wall Street Journal March 07, 2017 20:15 UTC